HIV and multidrug resistance
暂无分享,去创建一个
J. Condra | D. Graham | E. Emini | Emilio A. Emini | Jon H. Condra | Donald J. Graham | Leah Gotlib | Vera W. Byrnes | V. Byrnes | L. Gotlib
[1] D. Richman,et al. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] W. Schleif,et al. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Adams,et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. , 1990, Science.
[4] M. Hirsch,et al. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy , 1993, Nature.
[5] E A Emini,et al. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors , 1991, Journal of virology.
[6] S D Kemp,et al. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. , 1991, Science.
[7] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.